FDA approved Edwards’ Autus valve, the first heart valve built to grow with a child. President Trump announced $90 payments to Medicare enrollees a month before the midterms, and CMS’s 2027 data show Medicare Advantage insurers cutting plans and benefits.
CMS canceled marketplace coverage for more than 760,000 people and froze new broker registrations, the White House dropped its plan for political review of NIH grants, and FDA advisers backed the first multicancer blood test.
The White House moved toward a veto over NIH grants this week, and new records showed how hastily Medicare launched its AI prior-authorization pilot.
Medicare rewrote the coverage standard for TAVR this week and quietly opened a second one for aortic regurgitation.
Comment season closed on the 2027 payment rules and hospitals answered on every front at once, medical societies wrote their own vaccine schedule, and Edwards’ size-adjustable pulmonary valve reached its first American patient.
HHS opened a comment period on whether vaccines should still be routinely recommended, CMS put its RAPID device coverage pathway out for comment and paused TCET for new candidates, and No Surprises Act arbitration passed $22 billion in cost.
Receive our Policy Digest in your email inbox each week.
Savage Health Policy
csavage@shpconsulting.llc
(276) 221-8300
Please provide your contact information below and we will reply to you shortly.
